Supernus Pharmaceuticals Stock Price History

SUPN Stock  USD 38.69  0.31  0.79%   
If you're considering investing in Supernus Stock, it is important to understand the factors that can impact its price. As of today, the current price of Supernus Pharmaceuticals stands at 38.69, as last reported on the 30th of January, with the highest price reaching 39.88 and the lowest price hitting 38.59 during the day. Supernus Pharmaceuticals appears to be very steady, given 3 months investment horizon. Supernus Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Supernus Pharmaceuticals, which you can use to evaluate the volatility of the company. Please review Supernus Pharmaceuticals' Semi Deviation of 1.27, risk adjusted performance of 0.1129, and Coefficient Of Variation of 776.64 to confirm if our risk estimates are consistent with your expectations.
  
Supernus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1288

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsSUPN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.81
  actual daily
16
84% of assets are more volatile

Expected Return

 0.23
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.13
  actual daily
10
90% of assets perform better
Based on monthly moving average Supernus Pharmaceuticals is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Supernus Pharmaceuticals by adding it to a well-diversified portfolio.

Supernus Pharmaceuticals Stock Price History Chart

There are several ways to analyze Supernus Stock price data. The simplest method is using a basic Supernus candlestick price chart, which shows Supernus Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 27, 202539.41
Lowest PriceNovember 1, 202433.97

Supernus Pharmaceuticals January 30, 2025 Stock Price Synopsis

Various analyses of Supernus Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Supernus Stock. It can be used to describe the percentage change in the price of Supernus Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Supernus Stock.
Supernus Pharmaceuticals Accumulation Distribution 8,844 
Supernus Pharmaceuticals Price Rate Of Daily Change 0.99 
Supernus Pharmaceuticals Price Daily Balance Of Power(0.24)
Supernus Pharmaceuticals Price Action Indicator(0.70)

Supernus Pharmaceuticals January 30, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Supernus Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Supernus Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Supernus Stock and then apply it to test your longer-term investment strategies against Supernus.

Supernus Stock Price History Data

The price series of Supernus Pharmaceuticals for the period between Fri, Nov 1, 2024 and Thu, Jan 30, 2025 has a statistical range of 5.44 with a coefficient of variation of 3.15. The price distribution for the period has arithmetic mean of 36.85. The median price for the last 90 days is 36.85.
OpenHighLowCloseVolume
01/30/2025 39.40  39.88  38.59  38.69  273,411 
01/29/2025 39.15  39.36  38.20  39.00  255,211 
01/28/2025 39.39  39.69  38.94  39.15  212,471 
01/27/2025 38.76  39.69  38.20  39.41  275,728 
01/24/2025 38.38  39.24  38.38  38.55  330,139 
01/23/2025 38.16  38.85  38.00  38.64  446,793 
01/22/2025 38.50  38.66  37.91  38.17  384,790 
01/21/2025 37.93  38.65  37.93  38.58  177,828 
01/17/2025 37.92  38.13  37.27  37.74  199,736 
01/16/2025 38.20  38.68  37.85  37.87  312,023 
01/15/2025 38.21  38.43  37.53  38.31  333,899 
01/14/2025 37.70  37.98  37.40  37.82  221,860 
01/13/2025 37.36  38.06  37.08  37.57  301,175 
01/10/2025 37.58  37.85  36.80  37.49  371,611 
01/08/2025 37.23  38.31  36.76  38.06  294,535 
01/07/2025 36.62  37.55  36.48  37.43  248,828 
01/06/2025 37.50  38.33  36.80  37.05  869,473 
01/03/2025 36.49  36.93  36.28  36.92  405,852 
01/02/2025 36.27  36.90  36.10  36.43  323,848 
12/31/2024 36.91  37.05  35.73  36.16  354,549 
12/30/2024 36.68  37.28  35.96  36.91  493,543 
12/27/2024 36.05  37.34  35.70  37.18  597,506 
12/26/2024 35.42  36.29  35.38  36.28  160,362 
12/24/2024 35.44  35.64  34.78  35.60  125,303 
12/23/2024 35.37  35.66  34.81  35.59  264,032 
12/20/2024 35.42  36.29  34.38  35.43  1,057,620 
12/19/2024 35.50  35.79  35.00  35.77  273,466 
12/18/2024 36.24  36.79  35.18  35.46  321,312 
12/17/2024 37.35  37.35  36.15  36.22  311,502 
12/16/2024 36.20  37.07  35.96  36.49  369,418 
12/13/2024 37.28  37.28  35.68  36.17  455,557 
12/12/2024 36.87  36.97  36.11  36.16  507,553 
12/11/2024 37.01  37.28  36.59  36.85  253,580 
12/10/2024 36.79  37.27  36.48  36.74  236,515 
12/09/2024 37.19  37.62  36.60  36.68  272,626 
12/06/2024 37.12  37.48  36.74  37.17  220,367 
12/05/2024 36.83  37.44  36.20  36.99  246,689 
12/04/2024 36.84  37.52  36.67  37.15  271,008 
12/03/2024 37.24  37.24  36.21  37.03  399,095 
12/02/2024 36.45  37.41  36.16  37.31  352,905 
11/29/2024 36.91  37.05  36.15  36.57  223,863 
11/27/2024 36.43  37.23  36.03  36.99  504,763 
11/26/2024 36.11  36.59  35.85  36.14  202,164 
11/25/2024 36.55  37.21  36.10  36.10  283,774 
11/22/2024 36.08  36.66  35.85  36.22  208,168 
11/21/2024 36.30  36.53  35.53  35.82  231,925 
11/20/2024 35.66  36.50  35.32  36.12  203,916 
11/19/2024 34.88  35.64  34.88  35.53  211,604 
11/18/2024 35.61  36.20  34.86  35.25  223,995 
11/15/2024 36.39  36.39  35.23  35.57  403,290 
11/14/2024 37.78  38.32  35.87  36.18  370,984 
11/13/2024 37.94  38.32  37.18  37.77  403,586 
11/12/2024 36.84  37.99  36.84  37.83  425,682 
11/11/2024 36.93  37.27  36.02  36.61  266,696 
11/08/2024 36.50  36.78  35.87  36.60  578,650 
11/07/2024 37.75  37.75  36.23  36.40  788,445 
11/06/2024 35.88  38.21  35.33  37.75  724,712 
11/05/2024 39.37  39.37  33.43  34.74  945,025 
11/04/2024 33.96  34.96  33.70  34.70  450,619 
11/01/2024 34.22  34.55  33.80  33.97  788,776 
10/31/2024 34.69  35.03  34.01  34.07  377,694 

About Supernus Pharmaceuticals Stock history

Supernus Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Supernus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Supernus Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Supernus Pharmaceuticals stock prices may prove useful in developing a viable investing in Supernus Pharmaceuticals
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. The company was incorporated in 2005 and is headquartered in Rockville, Maryland. Supernus Pharm operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 603 people.

Supernus Pharmaceuticals Stock Technical Analysis

Supernus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Supernus Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Supernus Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Supernus Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Supernus Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Supernus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Supernus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Supernus Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Supernus Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Supernus Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Supernus Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Supernus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Supernus Pharmaceuticals. If investors know Supernus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Supernus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Supernus Pharmaceuticals is measured differently than its book value, which is the value of Supernus that is recorded on the company's balance sheet. Investors also form their own opinion of Supernus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Supernus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Supernus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Supernus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Supernus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Supernus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Supernus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.